Eur Heart J. 2014 Dec 14;35(47):3336-45. doi: 10.1093/eurheartj/ehu424.
Systematic reviews and meta-analyses allow for a more transparent and objective appraisal of the evidence. They may decrease the number of false-negative results and prevent delays in the introduction of effective interventions into clinical practice. However, as for any other tool, their misuse can result in severely misleading results. In this article,we discuss the main steps that should be taken when conducting systematic reviews and meta-analyses, namely the preparation of a review protocol, identification of eligible trials, and data extraction, pooling of treatment effects across trials, investigation of potential reasons for differences in treatment effects across trials, and complete reporting of the review methods and findings.We also discuss common pitfalls that should be avoided, including the use of quality assessment tools to derive summary quality scores, pooling of data across trials as if they belonged to a single large trial, and inappropriate uses of meta-regression that could result in misleading estimates of treatment effects because of regression to the mean or the ecological fallacy. If conducted and reported properly, systematic reviews and meta-analyses will increase our understanding of the strengths and weaknesses of the available evidence, which may eventually facilitate clinical decision making.
系统评价和荟萃分析可以更透明和客观地评估证据。它们可以减少假阴性结果的数量,并防止有效的干预措施在临床实践中被延迟引入。然而,就像任何其他工具一样,如果使用不当,它们可能会导致严重误导的结果。在本文中,我们讨论了进行系统评价和荟萃分析时应采取的主要步骤,即制定综述方案、确定合格的试验以及提取数据、跨试验汇总治疗效果、调查试验间治疗效果差异的潜在原因,以及完整报告综述方法和结果。我们还讨论了应避免的常见陷阱,包括使用质量评估工具得出综合质量评分、将数据跨试验汇总,就好像它们属于单个大型试验一样,以及meta 回归的不当使用,这可能会由于均值回归或生态谬误导致对治疗效果的误导估计。如果正确进行和报告,系统评价和荟萃分析将增加我们对现有证据的优缺点的理解,这最终可能有助于临床决策。